Pesquisas alternativas:
dermatol venereol » dermato venereology (Expandir a Pesquisa), dermato venereologie (Expandir a Pesquisa)
onutr acar » onur acar (Expandir a Pesquisa), nur acar (Expandir a Pesquisa)
nurs acar » nur acar (Expandir a Pesquisa), nuran acar (Expandir a Pesquisa), nuray acar (Expandir a Pesquisa)
eur acad » nur acar (Expandir a Pesquisa), eur ace (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 430 para a pesquisa 'j ((eur acad) OR (((nurs acar) OR (onutr acar)))) dermatol venereol~', tempo de pesquisa: 6.20seg Refinar resultados
COVID‐19 and its implications for Dermatology and Venereology
Dermato‐venereology in the year of coronavirus – Hot topics in research and patient care

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
Head-to-head trials of systemic psoriasis therapies: A systematic review of study design and maximum acceptable treatment differences.

Real‐life effectiveness of once‐daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52‐week PRO‐long study
The skin in the era of coronavirus pandemic

Impact of the COVID‐19 pandemic on inpatient dermatology: a multicentre study from Hubei, China
Baseline patient‐reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice

Acro‐ischaemia and COVID‐19 infection: clinical and histopathological features
Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry

Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease 2019: a short‐term, self‐controlled study
Measurement of Tanning Dependence

Occupational skin disease during the COVID‐19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom
Concerns and perceptions of patients with psoriatic disease during the COVID‐19 pandemic: results from a two‐wave survey by the National Psoriasis Foundation

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis
Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study

Response to IL‐17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein‐coding and untranslated regions of the IL‐17A gene: results from a multicentre study of four European psoriasis cohorts
Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study

Hyperspectral measurement of skin reflectance detects differences in the visible and near-infrared regions according to race, gender and body site
Catastrophic acute bilateral lower limbs necrosis associated with COVID‐19 as a likely consequence of both vasculitis and coagulopathy

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa